Real-World Practice Patterns for Prevention and Management of Potential Adverse Events with Pirfenidone in Patients with Idiopathic Pulmonary Fibrosis

INTRODUCTION: Pirfenidone is an oral antifibrotic agent approved for idiopathic pulmonary fibrosis (IPF). Real-world data on adverse event (AE) management for pirfenidone are limited. Strategies for managing potential antifibrotic therapy AEs were examined in a sample of US pulmonologists. METHODS:...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Pulm Ther
Main Authors: Wencel, Mark L., Haselkorn, Tmirah, Limb, Susan L., Stauffer, John L., Morgenthien, Elizabeth, Raimundo, Karina, LaCamera, Peter P.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Healthcare Communications 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6967051/
https://ncbi.nlm.nih.gov/pubmed/32026247
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s41030-018-0056-8
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados